Skip to content
Angion Biomedica Corp

Angion Biomedica Corp

ANGION IS A LATE-STAGE CLINICAL COMPANY DEVELOPING SMALL MOLECULES TARGETING ACUTE ORGAN INJURY AND CHRONIC FIBROSIS

  • about
    • executive management
    • scientific advisory board
    • board of directors
  • our science
    • organ fibrosis
    • HGF/c-met pathway
  • pipeline
    • ANG-3070
    • ANG-3777
    • ROCK2 Inhibitor
    • CYP11B2 Inhibitor
  • Investors
    • stock information
      • stock quote & chart
      • historic price lookup
    • analyst coverage
    • press releases
    • events & presentations
    • sec filings
    • governance
    • investor resources
      • investor contact
      • investor FAQs
      • email alerts
  • publications
  • careers
  • contact

angion publications

Renal Function Improvement Following ANG-3777 Treatment in Patients at High Risk for Delayed Graft Function After Kidney Transplantation


April 2020 – Transplantation
Posted in angion publications

ANG-3070 is a Highly-Selective, Orally-Available TKI in Development for Pulmonary and Renal Fibrosis


May 2022 - American Thoracic Society Respiratory Innovation Summit
Posted in angion publications

Phase 2 Study Design to Evaluate Safety and Efficacy of the Tyrosine Kinase Inhibitor ANG-3070 in Patients with Primary Proteinuric Kidney Disease


November 2021 - ASN Kidney Week
Posted in angion publications

Effect of ANG-3070 in the Passive Heymann’s Nephritis Rat Model of Primary Proteinuric Kidney Disease


November 2021 - ASN Kidney Week
Posted in angion publications

Effects of ANG-3070 in a Mouse Model of Alport Syndrome


November 2021 - ASN Kidney Week
Posted in angion publications

Effect of ANG-3070 in the Unilateral Ureteral Obstruction Mouse Model of Renal Fibrosis


November 2021 - ASN Kidney Week
Posted in angion publications

Costs in the Year Following Deceased Donor Kidney Transplantation: Relationships with Renal Function and Graft Failure


June 2021 - American Transplant Congress
Posted in angion publications

Hepatocyte Growth Factor Mimetic ANG-3777 for Cardiac Surgery–Associated Acute Kidney Injury


October 2020 - Kidney Reports International
Posted in angion publications

The Effect of ANG-3777 on the Growth of c-Met Expressing Tumor Cells in Immunocompromised Mice


October 2020 - Kidney Week
Posted in angion publications

Defining a Clinically-Meaningful Difference (MCMD) in Estimated Glomerular Filtration Rate (eGFR) for Kidney Transplantation


October 2020 - Kidney Week
Posted in angion publications

Compartmental Differences Within the COL3A1 Network in Proteinuric Kidney Disease — Informing Drug Activity Using the Jaccard-Tanimoto Index


October 2020 - Kidney Week
Posted in angion publications

Posts navigation

Older posts

CATEGORIES

  • RSL-HGF
  • RSL-ALI
  • Fibrosis
  • ROCKi
  • angion publications
  • RSL-AKI
  • events

CORPORATE ADDRESS

51 Charles Lindbergh Boulevard
Uniondale, NY 11553

Navigation

  • home
  • about
  • our science
  • pipeline
  • investors
  • publications
  • careers
  • contact

© 2022 Angion. All Rights Reserved.
Legal and Privacy Policy

NEW YORK | BOSTON | AUSTRALIA